top of page
Oils-Web.jpg

An Educational Guide to Cannabis Oils and Tinctures

As medicinal cannabis becomes more widely prescribed across Australia, many patients and healthcare professionals are turning to cannabis oils and tinctures as a safe, precise, and controlled way to administer cannabinoids.
 

These formulations offer consistent dosing, long-lasting effects, and ease of use, making them one of the most common product types prescribed under Australia’s Therapeutic Goods Administration (TGA) framework (Therapeutic Goods Administration, 2023).
 

While both oils and tinctures contain active cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol), they differ in formulation and absorption method. Understanding these differences helps patients and prescribers choose the most suitable product for specific therapeutic goals.

What Are Cannabis Oils and Tinctures?

Cannabis oils are produced by extracting cannabinoids and terpenes from the cannabis plant and suspending them in a carrier oil, such as medium-chain triglyceride (MCT), olive oil or hemp seed oil (Grotenhermen, 2003).

Tinctures, on the other hand, are alcohol-based extracts where cannabinoids are dissolved in high-proof ethanol. While tinctures are more common in overseas markets, most Australian medicinal cannabis products are oil-based formulations, as they meet the Therapeutic Goods Order No. 93 (TGO 93) standards for safety and purity (TGO 93, 2022).

Both oils and tinctures are typically administered orally either sublingually (under the tongue) or swallowed directly.

How Cannabis Oils and Tinctures Work

When swallowed, these oils are absorbed by the small intestine then undergo first-pass metabolism in the liver, leading to a delayed onset (1–2 hours) but a longer duration of effect, often lasting 6–8 hours (Grotenhermen, 2003).

The therapeutic effects of oils and tinctures depend on their cannabinoid ratio and terpene profile:

  • THC-dominant formulations: May support pain relief, appetite stimulation, and sleep.
     

  • CBD-dominant formulations: Non-intoxicating; may assist with anxiety, inflammation, and seizure control (MacCallum & Russo, 2018).
     

  • Balanced THC:CBD oils: May offer therapeutic synergy through the entourage effect of the combined interaction of cannabinoids and terpenes (Russo, 2019).
     

Because oral ingestion results in slower onset and longer duration, oils and tinctures are ideal for ongoing symptom management, whereas vaporised flower may be preferred for acute or breakthrough symptoms (Swift et al., 2021).

Benefits of Cannabis Oils and Tinctures

Cannabis oils and tinctures offer several advantages in the context of Australian medicinal cannabis therapy:
 

  • Precise dosing: Each product has a standardised cannabinoid concentration, enabling predictable titration (Therapeutic Goods Administration, 2023).
     

  • The precise dosing can be titrated more closely with oils, as they are dosed via a syringe.
     

  • Long-lasting effects: Beneficial for chronic pain, anxiety, or insomnia management (Grotenhermen, 2003).
     

  • Non-inhaled delivery: Ideal for patients with respiratory issues or who prefer not to vaporise.
     

  • Discreet and convenient: Simple to administer, with minimal odour and equipment.

Safety and Considerations

Although cannabis oils and tinctures are well tolerated by most patients, proper medical supervision and storage practices are essential.
 

  • Start low and go slow: Dosing should begin with small amounts, gradually increased under clinical guidance (MacCallum & Russo, 2018).
     

  • Storage: Keep oils in cool, dark places, ideally in airtight glass bottles to prevent cannabinoid degradation. Studies show that exposure to oxygen and UV light can degrade THC by up to 5% per week under suboptimal conditions (Trofin et al., 2012).

Conclusion

Cannabis oils and tinctures are a cornerstone of medicinal cannabis therapy in Australia, providing a controlled, smoke-free, and precise delivery method.

By offering consistent dosing, long-lasting effects, and patient-friendly administration, these products continue to play a major role in evidence-based cannabinoid medicine.

As clinical understanding and product innovation grow, oils and tinctures will remain at the forefront of modern medicinal cannabis therapy, helping patients manage chronic conditions in a controlled and compliant way.

Disclaimer: This post is for informational purposes only and does not constitute medical or legal advice. Laws regarding prescription medicines vary by region, and readers should always consult with a qualified healthcare provider before using any prescription medication.

​References: Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), 327–360. MacCallum, C. A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49, 12–19. Russo, E. B. (2019). The case for the entourage effect and conventional breeding of clinical cannabis: No “strain,” no gain. Frontiers in Plant Science, 9, 1969. Swift, W., et al. (2021). Patterns and experiences of medicinal cannabis use in Australia. Harm Reduction Journal, 18(1), 70. Therapeutic Goods Administration (TGA). (2023). Medicinal Cannabis Guidance Documents. Retrieved from https://www.tga.gov.au Therapeutic Goods Order No. 93 (TGO 93). (2022). Standard for Medicinal Cannabis. Commonwealth of Australia. Trofin, I. G., Dabija, G., Vaireanu, D. I., & Filipescu, L. (2012). The influence of storage conditions on the chemical potency of herbal cannabis. Revista de Chimie, 63(7), 674–678.

bottom of page